
    
      This study will enroll patients with in adequately controlled type 2 diabetes mellitus who
      have been on metformin (1,000 mg or above) for 8 weeks at least or longer and randomly add
      teneliglipin (20 mg/day) or sitagliptin (100 mg/day) for 4 weeks. Continuous glucose
      monitoring will be checked before and after 4-week administration of teneliglipin or
      sitagliptin together with mixed meal tolerance test (MMTT). Other efficacy and safety
      parameters will be also assessed.
    
  